Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors

Poorval M. Joshi, Shari L. Sutor, Catherine J. Huntoon, Larry M. Karnitz

Research output: Contribution to journal › Article › peer-review

111 Scopus citations

Fingerprint

Dive into the research topics of 'Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds